Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 11/2011

01-11-2011 | Original Article

Bleeding and Thromboembolic Outcomes for Patients on Oral Anticoagulation Undergoing Elective Colon and Rectal Abdominal Operations

Authors: Corey W. Iqbal, Robert R. Cima, John H. Pemberton

Published in: Journal of Gastrointestinal Surgery | Issue 11/2011

Login to get access

Abstract

Purpose

Patients on chronic oral anticoagulation can be challenging to manage in the perioperative period.

Methods

Review of patients on warfarin undergoing elective abdominal colon and rectal operations at a single institution from 2000 to 2006.

Results

One forty-six patients underwent 165 abdominal procedures. Mean (±SEM) age was 67 ± 1 years; 59% of patients were men. Median estimated blood loss was 200 ml, and 19% received intraoperative blood products while 19% of patients received a postoperative transfusion. Sixteen patients (10%) experienced bleeding complications (three requiring reoperation). No risk factors for bleeding were identified by multivariate analysis (MVA). Five patients (3%) suffered a postoperative thromboembolic event. Preoperative anticoagulation for cerebrovascular disease was a risk factor for thromboembolism (p = 0.03). Overall operative morbidity was 30% with no identifiable risk factor in MVA. Mortality was nil.

Conclusion

Postoperative bleeding and thromboembolism in patients on chronic anticoagulation are not insignificant (10% and 3%, respectively). Patients on warfarin for cerebrovascular disease are at increased risk for thromboembolic events postoperatively and should be placed on appropriate prophylaxis and monitored.
Literature
1.
go back to reference Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997; 336: 1506–11.PubMedCrossRef Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997; 336: 1506–11.PubMedCrossRef
2.
go back to reference Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. New Engl J Med. 1988; 318: 1162–73.PubMedCrossRef Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. New Engl J Med. 1988; 318: 1162–73.PubMedCrossRef
3.
go back to reference Mourelo R, Kaidar-Person O, Fajnwaks P, et al. Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. 2008; 18: 167–70. Mourelo R, Kaidar-Person O, Fajnwaks P, et al. Hemorrhagic and thromboembolic complications after bariatric surgery in patients receiving chronic anticoagulation therapy. 2008; 18: 167–70.
4.
go back to reference Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk for arterial embolism who require temporary interruption of warfarin. Circulation. 2004; 110: 1658–63.PubMedCrossRef Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk for arterial embolism who require temporary interruption of warfarin. Circulation. 2004; 110: 1658–63.PubMedCrossRef
5.
go back to reference Bajkin BV, Popovic SL, Selakovic SDJ. Randomized prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth. J Oral Maxillofac Surg. 2009; 67: 990–95.PubMedCrossRef Bajkin BV, Popovic SL, Selakovic SDJ. Randomized prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth. J Oral Maxillofac Surg. 2009; 67: 990–95.PubMedCrossRef
6.
go back to reference Ercan M, Bostanci EB, Ozer I, et al. Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg. 2010; 395: 247–53.PubMedCrossRef Ercan M, Bostanci EB, Ozer I, et al. Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy. Langenbecks Arch Surg. 2010; 395: 247–53.PubMedCrossRef
7.
go back to reference McLemore EC, Harold KL, Cha SS, Johnson DJ, Fowl RJ. The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg. 2006; 192: 860–64.PubMedCrossRef McLemore EC, Harold KL, Cha SS, Johnson DJ, Fowl RJ. The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg. 2006; 192: 860–64.PubMedCrossRef
8.
go back to reference Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg. 2010; 15: 19–113.CrossRef Edmunds I, Avakian Z. Hand surgery on anticoagulated patients: a prospective study of 121 operations. Hand Surg. 2010; 15: 19–113.CrossRef
9.
go back to reference Eng M, Brock G, Li X, et al. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transplant. 2011; 25: 292–96.PubMedCrossRef Eng M, Brock G, Li X, et al. Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? Clin Transplant. 2011; 25: 292–96.PubMedCrossRef
10.
go back to reference McBane RD, Wysokinski WE, Daniels PR, et al. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol. 2010; 30: 442–48.PubMedCrossRef McBane RD, Wysokinski WE, Daniels PR, et al. Periprocedural anticoagulation management of patients with venous thromboembolism. Arterioscler Thromb Vasc Biol. 2010; 30: 442–48.PubMedCrossRef
11.
go back to reference Jaffer AK, Brotman DJ, Bash LD, et al. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med. 2010; 123: 141–50.PubMedCrossRef Jaffer AK, Brotman DJ, Bash LD, et al. Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals. Am J Med. 2010; 123: 141–50.PubMedCrossRef
12.
go back to reference Dunn AS, Turpie AGG. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med. 2003; 163: 901–08.PubMedCrossRef Dunn AS, Turpie AGG. Perioperative management of patients receiving oral anticoagulants. Arch Intern Med. 2003; 163: 901–08.PubMedCrossRef
13.
go back to reference Carrel TP, Klinenman W, Mohacsi PJ, Berdat P, Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis. 1999; 8: 392–98.PubMed Carrel TP, Klinenman W, Mohacsi PJ, Berdat P, Althaus U. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review. J Heart Valve Dis. 1999; 8: 392–98.PubMed
14.
go back to reference Petty GW, Brown RD Jr, Whisnant JP, et al. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000; 31: 1062–68.PubMedCrossRef Petty GW, Brown RD Jr, Whisnant JP, et al. Ischemic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke. 2000; 31: 1062–68.PubMedCrossRef
15.
go back to reference Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1–7.PubMed Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1–7.PubMed
16.
go back to reference Thachil J, Gatt A, Martlew V. Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg. 2008; 95: 1437–48.PubMedCrossRef Thachil J, Gatt A, Martlew V. Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg. 2008; 95: 1437–48.PubMedCrossRef
17.
go back to reference Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Ed.). Chest. 2008; 133S: 299–339.CrossRef Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th Ed.). Chest. 2008; 133S: 299–339.CrossRef
18.
go back to reference O’Donnell MJ, Kearon C, Johnson J, et al. Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med. 2007; 146: 184–87.PubMed O’Donnell MJ, Kearon C, Johnson J, et al. Brief communication: preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin. Ann Intern Med. 2007; 146: 184–87.PubMed
19.
go back to reference Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet. 1993; 341: 259–65.PubMedCrossRef Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet. 1993; 341: 259–65.PubMedCrossRef
20.
go back to reference Tinmouth AH, Morrow BH, Cruickshank M, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother. 2001; 35: 669–74.PubMedCrossRef Tinmouth AH, Morrow BH, Cruickshank M, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother. 2001; 35: 669–74.PubMedCrossRef
21.
go back to reference Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh AACP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126S: 457–82.CrossRef Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart disease – native and prosthetic: the Seventh AACP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126S: 457–82.CrossRef
22.
go back to reference Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol. 2002; 25: 323–2CrossRef Shapira Y, Sagie A, Battler A. Low-molecular-weight heparin for the treatment of patients with mechanical heart valves. Clin Cardiol. 2002; 25: 323–2CrossRef
Metadata
Title
Bleeding and Thromboembolic Outcomes for Patients on Oral Anticoagulation Undergoing Elective Colon and Rectal Abdominal Operations
Authors
Corey W. Iqbal
Robert R. Cima
John H. Pemberton
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 11/2011
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-011-1611-x

Other articles of this Issue 11/2011

Journal of Gastrointestinal Surgery 11/2011 Go to the issue